Amazon no longer offers textbook rentals. We do!

The Maudsley Prescribing Guidelines in Psychiatry

by: Taylor, David; Paton, Carol; Kapur, Shitij

The Maudsley Prescribing Guidelines in Psychiatry

by: Taylor, David; Paton, Carol; Kapur, Shitij

ISBN 13:
9780470979488
ISBN 10:
0470979488
Edition: 11th
Format: Paperback
Copyright: 04/02/2012
Publisher: Wiley-Blackwell

Rent

Sorry, this item is currently unavailable.

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Extend or Purchase Your Rental at Any Time

Need to keep your rental past your due date? At any time before your due date you can extend or purchase your rental through your account.

Summary

The highly respected Maudsley Prescribing Guidelines are updated and revised in this new edition of a popular text.

Preface	p. ix
Acknowledgements	p. x
Notes on using The Maudsley Prescribing Guidelines	p. xi
Notes on inclusion of drugs	p. xi
List of abbreviations	p. xii
Plasma level monitoring of psychotropic drugs and anticonvulsants	p. 1
Interpreting sample results	p. 2
Schizophrenia	p. 11
Antipsychotic drugs	p. 11
Antipsychotic drugs: equivalent doses	p. 13
Antipsychotic drugs: minimum effective doses	p. 14
Antipsychotic drugs: licensed maximum doses	p. 16
New antipsychotic drugs	p. 17
Antipsychotic drugs: general principles of prescribing	p. 21
National Institute for Health and Clinical Excellence guidelines for the treatment of schizophrenia	p. 22
Treatment algorithms for schizophrenia	p. 24
Antipsychotic drugs: monitoring of metabolic effects	p. 26
Switching antipsychotic drugs because of poor tolerability	p. 31
Antipsychotic response: to increase the dose, to switch, to add or just wait-what is the right move?	p. 33
Speed and onset of antipsychotic drug action	p. 36
First-generation antipsychotic drugs: place in therapy	p. 39
Antipsychotic drugs: long-acting injections	p. 40
Risperidone long-acting injection	p. 44
Paliperidone palmitate long-acting injection	p. 47
Management of patients on long-term depots: dose reduction	p. 50
Combined antipsychotic drugs	p. 51
High-dose antipsychotic drugs: prescribing and monitoring	p. 54
Negative symptoms in schizophrenia	p. 57
Antipsychotic prophylaxis	p. 60
Refractory schizophrenia and clozapine	p. 64
Clozapine augmentation	p. 66
Refractory schizophrenia: alternatives to clozapine	p. 69
Clozapine: management of common adverse effects	p. 75
Clozapine: uncommon or unusual adverse effects	p. 78
Clozapine: serious haematological and cardiovascular adverse effects	p. 80
Clozapine, neutropenia and lithium	p. 84
Clozapine and chemotherapy	p. 88
Clozapine-related hypersalivation	p. 89
Guidelines for the initiation of clozapine for patients based in the community	p. 92
Omega-3 fatty acids fish oils in schizophrenia	p. 96
Extrapyramidal side-effects of antipsychotic drug treatment	p. 98
Treatment of antipsychotic-induced akathisia	p. 103
Treatment of tardive dyskinesia	p. 105
Neuroleptic malignant syndrome	p. 110
Catatonia	p. 113
Cardiovascular effects of antipsychotic drug treatment	p. 115
Antipsychotic drugs and hypertension	p. 122
Hyperprolactinaemia	p. 123
Antipsychotic-induced weight gain	p. 126
Treatment of drug-induced weight gain	p. 128
Antipsychotic drugs, diabetes and impaired glucose tolerance	p. 132
Antipsychotic drugs and dyslipidaemia	p. 138
Antipsychotic drugs and sexual dysfunction	p. 142
Antipsychotic-associated hyponatraemia	p. 148
Antipsychotics and pneumonia	p. 150
Relative adverse effects of antipsychotic drugs: a rough guide	p. 151
Bipolar disorder	p. 153
Valproate	p. 153
Lithium	p. 159
Carbamazepine	p. 168
Physical monitoring of people with bipolar disorder	p. 173
Treatment of acute mania or hypomania	p. 176
Antipsychotic drugs in bipolar disorder	p. 182
Bipolar depression	p. 185
Rapid cycling bipolar disorder	p. 191
Prophylaxis in bipolar disorder	p. 193
Depression and anxiety	p. 197
Depression	p. 197
Antidepressants	p. 201
Treatment of resistant depression	p. 222
Treatment of psychotic depression	p. 233
Electroconvulsive therapy and psychotropic drugs	p. 235
Psychostimulants in depression	p. 239
Treatment of depression in the elderly	p. 243
Treatment of depression in stroke	p. 247
Adverse effects of antidepressants	p. 249
Selective serotonin reuptake inhibitors and bleeding	p. 252
Depression and diabetes	p. 255
Cardiac effects of antidepressants	p. 257
Antidepressants and sexual dysfunction	p. 264
Antidepressants and hyperprolactinaemia	p. 268
Antidepressants: swapping and stopping	p. 270
St John's wort in the treatment of depression	p. 278
Drug interactions with antidepressants	p. 281
Alternative routes of administration for antidepressants	p. 286
Anxiety spectrum disorders	p. 292
Benzodiazepines in the treatment of psychiatric disorders	p. 301
Benzodiazepines and disinhibition	p. 304
Benzodiazepines: dependence and detoxification306
Insomnia	p. 310
Children and adolescents	p. 315
Principles of prescribing practice in childhood and adolescence	p. 315
Depression in children and adolescents	p. 316
Bipolar illness in children and adolescents	p. 321
Psychosis in children and adolescents	p. 326
Anxiety in children and adolescents	p. 327
Obsessive compulsive disorder in children and adolescents	p. 328
Attention deficit hyperactivity disorder	p. 332
Autism spectrum disorders	p. 337
Tics and Tourette's syndrome	p. 345
Melatonin in the treatment of insomnia in children and adolescents	p. 349
Rapid tranquillisation in children and adolescents	p. 351
Doses of commonly used psychotropic drugs in children and adolescents	p. 354
Substance misuse	p. 355
Alcohol dependence	p. 356
Opioid misuse and dependence	p. 372
Nicotine and smoking cessation	p. 398
Stimulant drugs of dependence	p. 406
Benzodiazepine misuse	p. 407
¿ -Butaryl-lactone and ¿ -hydroxybutyrate dependence	p. 408
Drugs of misuse: a summary	p. 410
Interactions between 'street drugs' and prescribed psychotropic drugs	p. 414
Use of psychotropic drugs in special patient groups	p. 419
Epilepsy	p. 419
Pregnancy	p. 430
Breast feeding	p. 446
Renal impairment	p. 462
Hepatic impairment	p. 478
Prescribing in the elderly	p. 487
Dementia	p. 490
Behavioural and psychological symptoms of dementia	p. 509
Parkinson's disease	p. 518
Multiple sclerosis	p. 522
Eating disorders	p. 527
Acutely disturbed or violent behaviour	p. 531
Psychotropic medications for adults with learning disabilities	p. 539
Borderline personality disorder	p. 545
Delirium	p. 547
Huntington's disease	p. 554
Psychotropic drugs and surgery	p. 558
Prescribing psychotropic drugs for patients with HIV infection	p. 564
Psychotropic drugs and cytochrome CYP function	p. 573
Summary of psychiatric side-effects of non-psychotropic drugs	p. 578
Miscellaneous conditions and substances	p. 587
Psychotropic drugs in overdose	p. 587
Biochemical and haematological effects of psychotropic drugs	p. 593
Prescribing drugs outside their licensed indications	p. 604
Observations on the placebo effect in mental illness	p. 606
Drug interactions with alcohol	p. 608
Nicotine	p. 613
Smoking and psychotropic drugs	p. 616
Caffeine	p. 618
Complementary therapies	p. 624
Enhancing medication adherence	p. 628
Driving and psychotropic medicines	p. 634
Covert administration of medicines within food and drink	p. 643
Index	p. 647
Table of Contents provided by Ingram. All Rights Reserved.

Amazon no longer offers textbook rentals. We do!

The Maudsley Prescribing Guidelines in Psychiatry

The Maudsley Prescribing Guidelines in Psychiatry

9780470979488

0470979488

Summary

Author Biography

Table of Contents

Supplemental Materials

Write a Review